AI assistant
DocGo Inc. — Earnings Release 2022
Jan 28, 2022
33981_rns_2022-01-28_7efa5074-c303-4ac8-8f0f-e1854fa41243.zip
Earnings Release
Open in viewerOpens in your device viewer
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Field: Rule-Page
Field: /Rule-Page
FORM 8-K
Field: Rule-Page
Field: /Rule-Page
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 28, 2022
DOCGO INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-39618 | 85-2515483 |
|---|---|---|
| (State or other jurisdiction | (Commission | (IRS Employer |
| of incorporation) | File Number) | Identification No.) |
| 35
West 35th Street , Floor 5 , New York , New York | 10001 |
| --- | --- |
| (Address
of principal executive offices) | (Zip
Code) |
(844) 443-6246
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title
of each class | Trading Symbol(s) | Name
of each exchange on which
registered |
| --- | --- | --- |
| Common
stock, par value $0.0001 per share | DCGO | The Nasdaq Stock Market LLC |
| Warrants,
each exercisable for one share of common stock at an exercise price of $11.50 per share | DCGOW | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
Item 2.02 Results of Operation and Financial Conditiom
On January 28, 2022, DocGo Inc. (the “Company”) issued a press release that announced preliminary unaudited earnings results for the quarter and fiscal year ended December 31, 2021, including preliminary unaudited revenue. This press release is furnished as Exhibit 99.1 to this report.
The information in Item 2.02 of this report and the exhibit attached hereto is being furnished and shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description |
|---|---|
| 99.1 | Press release of DocGo |
| Inc. dated January 28, 2022 | |
| 104 | Cover Page Interactive |
| Data File (formatted as Inline XBRL). |
Field: Page; Sequence: 2; Options: NewSection; Value: 1
Field: Sequence; Type: Arabic; Name: PageNo 1 Field: /Sequence
Field: /Page
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| /s/ Andre Oberholzer | |
|---|---|
| Name: | Andre Oberholzer |
| Title: | Chief Financial Officer |
Date: January 28, 2022
2
Field: Rule-Page
Field: /Rule-Page